-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The pharmaceutical equipment industry belongs to the upstream of the pharmaceutical industry, and its market situation is closely related to the medical reform policy, the development of the pharmaceutical industry, and the reform of the industry itself
.
From a policy perspective, a series of policies in recent years have been forcing the transformation and upgrading of the pharmaceutical industry, and pharmaceutical equipment is also in urgent need of transformation from low-end to mid-to-high-end; from the downstream perspective, in recent years, with the rapid development of biological drugs, The pharmaceutical equipment industry has ushered in a good opportunity
.
From the performance forecasts disclosed by major pharmaceutical machine companies in 2021, it can be seen that most companies are performing well, and Chutian Technology is expected to double its net profit in 2021
.
In addition, from the perspective of the industry itself, the biopharmaceutical equipment industry is showing the following two new trends, which are expected to bring more new opportunities to the industry
.
Pharmaceutical Equipment (Source: Pharmaceutical Network) Disposable bioreactors accelerate the replacement of traditional stainless steel tanks With the support of policies, talents, capital and other factors, China's biological drugs have developed rapidly in recent years
.
Data shows that China's biological drug market in 2020 is 400 billion yuan, and it is expected that by 2024, the market size will exceed 100 billion US dollars
.
The industry expects that with the rapid development of the biopharmaceutical industry and the continuous expansion of enterprise production capacity, the disposable system will gradually replace the traditional stainless steel reactor equipment
.
The reasons include: Compared with traditional stainless steel tanks, the disposable system has higher production efficiency, greater flexibility, shorter construction period, lower initial investment cost, and less possibility of cross-contamination between products.
The commercialization process and the reduction of business costs are of great significance
.
According to data, the current global market space for disposable bioreactors is about 1 billion to 2 billion US dollars, and it is expected to reach 3 billion to 4 billion US dollars by 2025, with an average annual growth rate of about 20%
.
In China, the proportion of single-use bioreactors used in the production of monoclonal antibodies has exceeded 70%
.
There is still a lot of room for growth in disposable bioreactors in the future
.
The author learned that the current pharmaceutical machine companies including Chutian Technology are actively deploying in the field of disposable bioreactors.
.
Not long ago, Chutian Technology mentioned in its research activities that the company has deployed disposable bioreactors, disposable liquid dispensing systems, ultrafiltration chromatography purification, stainless steel reactors and fillers
.
In the field of disposable consumables, the company has introduced relevant technical talents in the industry and established a holding company, Chutian Siyoute, for the development and production of disposable bioreactors, liquid dispensing bags, liquid storage bags and their membrane materials.
production
.
Continuous production has become a trend In the field of cells, continuous production refers to the continuous process from upstream cell culture to flow addition, concentrated flow addition, and perfusion.
This production method is conducive to reducing the development and production of new drugs by pharmaceutical companies.
time and reduce the associated costs for the business
.
It is understood that in western countries such as Germany, Japan and the United States, the application of continuous production technology in pharmaceutical factories is relatively early, while the pharmaceutical equipment industry in China has a late start and has long been dominated by the traditional production mode of single equipment
.
In recent years, with the advancement of policies such as consistency evaluation, pharmaceutical companies have gradually realized the importance of continuous production to enterprises
.
It is expected in the industry that with the rapid development of the pharmaceutical industry and the rising cost of pharmaceuticals year by year, the iteration of the continuous production process of pharmaceutical companies will become a trend
.
In this context, related continuous equipment such as continuous granulator and continuous freeze dryer will also gain new opportunities
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
From a policy perspective, a series of policies in recent years have been forcing the transformation and upgrading of the pharmaceutical industry, and pharmaceutical equipment is also in urgent need of transformation from low-end to mid-to-high-end; from the downstream perspective, in recent years, with the rapid development of biological drugs, The pharmaceutical equipment industry has ushered in a good opportunity
.
From the performance forecasts disclosed by major pharmaceutical machine companies in 2021, it can be seen that most companies are performing well, and Chutian Technology is expected to double its net profit in 2021
.
In addition, from the perspective of the industry itself, the biopharmaceutical equipment industry is showing the following two new trends, which are expected to bring more new opportunities to the industry
.
Pharmaceutical Equipment (Source: Pharmaceutical Network) Disposable bioreactors accelerate the replacement of traditional stainless steel tanks With the support of policies, talents, capital and other factors, China's biological drugs have developed rapidly in recent years
.
Data shows that China's biological drug market in 2020 is 400 billion yuan, and it is expected that by 2024, the market size will exceed 100 billion US dollars
.
The industry expects that with the rapid development of the biopharmaceutical industry and the continuous expansion of enterprise production capacity, the disposable system will gradually replace the traditional stainless steel reactor equipment
.
The reasons include: Compared with traditional stainless steel tanks, the disposable system has higher production efficiency, greater flexibility, shorter construction period, lower initial investment cost, and less possibility of cross-contamination between products.
The commercialization process and the reduction of business costs are of great significance
.
According to data, the current global market space for disposable bioreactors is about 1 billion to 2 billion US dollars, and it is expected to reach 3 billion to 4 billion US dollars by 2025, with an average annual growth rate of about 20%
.
In China, the proportion of single-use bioreactors used in the production of monoclonal antibodies has exceeded 70%
.
There is still a lot of room for growth in disposable bioreactors in the future
.
The author learned that the current pharmaceutical machine companies including Chutian Technology are actively deploying in the field of disposable bioreactors.
.
Not long ago, Chutian Technology mentioned in its research activities that the company has deployed disposable bioreactors, disposable liquid dispensing systems, ultrafiltration chromatography purification, stainless steel reactors and fillers
.
In the field of disposable consumables, the company has introduced relevant technical talents in the industry and established a holding company, Chutian Siyoute, for the development and production of disposable bioreactors, liquid dispensing bags, liquid storage bags and their membrane materials.
production
.
Continuous production has become a trend In the field of cells, continuous production refers to the continuous process from upstream cell culture to flow addition, concentrated flow addition, and perfusion.
This production method is conducive to reducing the development and production of new drugs by pharmaceutical companies.
time and reduce the associated costs for the business
.
It is understood that in western countries such as Germany, Japan and the United States, the application of continuous production technology in pharmaceutical factories is relatively early, while the pharmaceutical equipment industry in China has a late start and has long been dominated by the traditional production mode of single equipment
.
In recent years, with the advancement of policies such as consistency evaluation, pharmaceutical companies have gradually realized the importance of continuous production to enterprises
.
It is expected in the industry that with the rapid development of the pharmaceutical industry and the rising cost of pharmaceuticals year by year, the iteration of the continuous production process of pharmaceutical companies will become a trend
.
In this context, related continuous equipment such as continuous granulator and continuous freeze dryer will also gain new opportunities
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
